LM

Leslie Mi Ok Chong

Ms Chong joined the Group in September 2015 from the oncology clinical development company, Genentech (a member of the Roche family), where she was a Senior Clinical Program Lead at the head office in San Francisco. She has over 25 years of experience in clinical and department development in oncology.

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
IMU
IMU
30/06/263,269,284220,718174,020N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
IMU
IMU
30/06/26
Expiry
508,824$0.115$58,514Options expired
IMU
IMU
14/05/26
Buy
355,164$0.102$36,404On-market trade
IMU
IMU
11/05/26
Buy
230,285$0.107$24,755On-market trade
IMU
IMU
16/04/26
Buy
65,053$0.145$9,432On-market trade
IMU
IMU
15/12/25
Issued
751,621$0.315$236,760Employee Share Ownership Plan